DigitalDx Ventures

DigitalDx Ventures is a healthcare-focused early-stage venture firm with a thesis centered on digital diagnostics, AI-driven diagnostic software, and adjacent diagnostic technology platforms. The firm has an active website, LinkedIn, and Crunchbase presence, with a clearly scoped sector focus that distinguishes it from generalist digital health investors. For healthcare AI founders, DigitalDx is a strongly thesis-aligned potential lead or co-lead at seed and Series A if you are building AI-powered diagnostic software, including pathology AI, radiology AI, ophthalmology AI, dermatology AI, in vitro diagnostics with computational components, or related diagnostic decision support. Check sizes typically range from $500K to $3M at seed and Series A, with the firm capable of leading rounds and bringing deep diagnostic-sector expertise. Founders building therapeutics, care delivery models, payer-facing AI, or generic clinical workflow software outside the diagnostic core are unlikely to find a fit; the thesis is sharply scoped to diagnostics and adjacent computational decision support. The firm’s value-add is exceptional within its mandate, including diagnostics regulatory expertise, FDA pathway guidance, lab and pathology partnership networks, and credibility with diagnostic-focused follow-on capital. Entry path is LinkedIn outreach to the partners, the website inquiry form, or warm referral from a portfolio CEO or diagnostics ecosystem operator. Founders should come prepared with deep clinical evidence, FDA regulatory strategy, real-world performance data, and a commercial plan oriented toward labs, hospitals, and payers. Diagnostic AI founders with credible technical and clinical depth should treat DigitalDx as a top-priority outreach target; founders outside the diagnostics vertical should look to broader digital health investors instead.